Posted: 26 July 2023 Are you part of the specialist digital health workforce? Are you responsible for health data, information, knowledge, or technology? Be part of the census that captures the vital information about this workforce. This information…
Posted: 25 July 2023 MTPConnect and the Minister for Health and Aged Care, Hon. Mark Butler MP, today announced $6.2 million of funding for six medical technology projects through the Clinical Translation and Commercialisation Medtech (CTCM) Program. The CTCM program, a Medical…
Posted: 25 July 2023 Digital health company Cardihab has recently announced a partnership with Roche Diagnostics Australia Pty Ltd that is focused on improving quality and standards of care, that deliver better outcomes for people living with cardiovascular conditions in Australia.…
Posted: 25 July 2023 The Albanese Government has provided $1.1 million towards development of a new scanner which could revolutionise diagnosis of deadly lung conditions around the world. The XV-Perfusion lung scanner measures both ventilation (air flow) and…
Posted: 24 July 2023 A new National Cell and Gene Manufacturing Blueprint launched today, outlining how, with a united and coordinated plan, Australia can realise its potential to become a cell and gene (C&G) manufacturing hub for within…
Posted: 24 July 2023 Breakthrough research has found that Group A Streptococcus (GAS) infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection. This major discovery has far-reaching implications…
Posted: 24 July 2023 Dimerix Limited (ASX: DXB) a biopharmaceutical company with a Phase 3 clinical study in inflammatory diseases, today confirmed that the first 72 patients have been randomised in its DMX-200 ACTION3 phase 3 trial in…
Posted: 24 July 2023 Starpharma (ASX: SPL, OTCQX: SPHRY) today announces that DEP® HER2-zirconium, its HER2-targeted radiodiagnostic candidate, has demonstrated a favourable biodistribution profile, with excellent imaging contrast between tumour and normal tissues, as well as rapid uptake and high levels…
Posted: 24 July 2023 The Defense Advanced Research Projects Agency (DARPA) announced that Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, has been awarded a 4-year contract worth up to $18…
Posted: 24 July 2023 Telix today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA, Darmstadt, Germany (Merck) DNA-dependent protein…
Posted: 20 July 2023 The two will collaborate on development projects to bring new therapies to market. BioCurate, an independently operated joint venture between The University of Melbourne and Monash University, and NLC, the European Healthtech Venture Builder based in…
Posted: 19 July 2023 Introducing the Victorian Connected Health Innovation and Commercialisation Centre (CHICC) – a co-working, mentoring and workshop space designed specifically for Victorian-based digital and connected health companies! Created to boost the growth of digital and…